CanSino Biologics Inc 6185-HK:Hong Kong Stock Exchange

*Data is delayed | Exchange | HKD
Last | 4:08 PM CTT
20.45UNCH (UNCH)
Volume
1,344,620
52 week range
14.80 - 35.10
Loading...
  • Open21.05
  • Day High21.15
  • Day Low19.90
  • Prev Close20.45
  • 52 Week High35.10
  • 52 Week High Date05/16/23
  • 52 Week Low14.80
  • 52 Week Low Date02/05/24

Key Stats

  • Market Cap687.02M
  • Shares Out247.04M
  • 10 Day Average Volume1.38M
  • Dividend-
  • Dividend Yield-
  • Beta0.49
  • YTD % Change-13.16

KEY STATS

  • Open21.05
  • Day High21.15
  • Day Low19.90
  • Prev Close20.45
  • 52 Week High35.10
  • 52 Week High Date05/16/23
  • 52 Week Low14.80
  • 52 Week Low Date02/05/24
  • Market Cap687.02M
  • Shares Out247.04M
  • 10 Day Average Volume1.38M
  • Dividend-
  • Dividend Yield-
  • Beta0.49
  • YTD % Change-13.16

RATIOS/PROFITABILITY

  • EPS (TTM)-6.61
  • P/E (TTM)-3.09
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-
  • ROE (TTM)-
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On CanSino Biologics Inc

 

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
CanSino Biologics Inc is a clinical-stage vaccine company in China. The Company's products include Ad5-EBOV vaccine used for Ebola virus, MCV2 and MCV4 vaccines for meningococcus, PBPV vaccine used for pneumococcal and the recombinant novel coronavirus vaccine. Its products are mainly used in meningitis, diphtheria pertussis tetanus (DPT) and pneumonia.
Xuefeng Yu
Executive Chairman of the Board, Chief Executive Officer, General Manager
Shoubai Chao
Chief Operating Officer, Deputy General Manager, Executive Director
Address
West District Biomedical Park, No. 185
South Avenue, West District, Economic
Tianjin, TNJ
300457
China